MACOM Technology Solutions Holdings: Recent Performance Snapshot

MACOM Technology Solutions Holdings (MTSI) has drawn fresh attention after a strong share price move over the past month, alongside double digit annual revenue and net income growth and a market value of about US$19.9b.

The recent 30 day share price return of 26.79% and year to date share price return of 51.81% sit alongside a very large 1 year total shareholder return of 156.01%. This signals strong momentum despite the latest 1 day pullback of 4.95%.

If you are comparing MACOM with other semiconductor names benefiting from AI infrastructure demand, it could be worth scanning 38 AI infrastructure stocks

After such strong recent returns and double digit growth in revenue and net income, the key question is whether MACOM is still trading below its fair value, or if the market is already pricing in future growth.

Most Popular Narrative: 5% Undervalued

The most followed narrative sees MACOM’s fair value at about $279.73, slightly above the last close of $265.61, and builds a case on future earnings power rather than today’s multiples.

Ongoing investments in proprietary, high-value R&D and targeted M&A (with $735M in cash and a net cash position) enhance MACOM's ability to rapidly innovate for future optical, RF, and mixed-signal applications, which should further accelerate EPS and free cash flow growth as emerging standards and systems ramp up in coming years.

Curious what kind of revenue path, margin lift, and future P/E this narrative leans on. The fair value hangs on a tight set of growth and profitability assumptions, plus a premium multiple that is anything but ordinary.

Result: Fair Value of $279.73 (UNDERVALUED)

However, this upbeat story still leans on smoother fab execution and less volatile data center and telecom demand than recent management commentary suggests.

Another Angle On Valuation

The popular fair value narrative points to a small 5% upside, yet MACOM currently trades on a P/E of 122.9x versus 49.2x for the US Semiconductor industry, 50.6x for peers, and a fair ratio of 35.8x. That kind of gap raises a simple question: how much optimism is already in the price?

Next Steps

Seeing both optimism and concern in this story, it makes sense to check the numbers for yourself and quickly form your own view using 2 key rewards and 1 important warning sign

Ready to broaden your watchlist?

If MACOM has sparked your interest, do not stop here. Use the Simply Wall Street Screener to line up fresh ideas before the next move passes you by.

• Spot opportunities that combine quality and value by scanning 53 high quality undervalued stocks and see which names currently stand out.
• Prioritise resilience by checking 72 resilient stocks with low risk scores so you can focus on companies with more robust risk profiles.
• Hunt for names that the market may be overlooking using the screener containing 25 high quality undiscovered gems and see what others might be missing.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.